Clinical trial
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
NCT07300969
Study timeline
Study start (actual)2025-12-16Date precision: day
Registry last updated2026-08-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorder (MDD)unresolved
Interventions
Sponsors & collaborators
Draig Therapeutics Ltdlead sponsor
Mapped research locations
SofiaBulgaria4LondonUnited Kingdom2AustinTexas, United States2New YorkNew York, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1San DiegoCalifornia, United States1OrlandoFlorida, United States1Las VegasNevada, United States1PragueCzechia1Little RockArkansas, United States1PoznanPoland1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07300969 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.